a EK
Generic Name: erythromycin
Pill imprint a EK has been identified as Pce dispertab 500 mg.
PCE Dispertab is used in the treatment of chlamydia infection; dental abscess; strep throat; syphilis, early; bowel preparation (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy.
PCE Dispertab 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Pce dispertab Images
- Generic Name:
- erythromycin
- Imprint:
-
a EK
- Strength:
- 500 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- propylene glycol
stearic acid
magnesium silicate
titanium dioxide
silicon dioxide
crospovidone
polyethylene glycol
povidone
vanillin
microcrystalline cellulose
iron
citric acid monohydrate
- Drug Class:
- Macrolides
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Abbott Laboratories
- National Drug Code (NDC):
- 00074-3389
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55289-0027 | PDRX Pharmaceuticals Inc (repackager) |
| 54868-1774 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More PCE Dispertab resources
- PCE (Wolters Kluwer)
- PCE Dispertab (Cerner Multum)
- PCE (FDA)
PCE Dispertab is associated with the treatment of:
- Bacterial Endocarditis Prevention
- Bartonellosis
- Bowel Preparation
- Bronchitis
- Bullous Pemphigoid
- Campylobacter Gastroenteritis
- Chancroid
- Chlamydia Infection
- Dental Abscess
- Legionella Pneumonia
- Lyme Disease
- Lymphogranuloma Venereum
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Ocular Rosacea
- Otitis Media
- Pemphigoid
- Pertussis
- Pharyngitis
- Pneumonia
- Rheumatic Fever Prophylaxis
- Skin Infection
- Strep Throat
- Syphilis, Early
- Upper Respiratory Tract Infection
Search Again
